Acetaminophen (N-acetyl-
para-aminophenol;
APAP) overdose is the most common cause of
acute liver failure in the Western world, with limited treatment opportunities. For years, research on
APAP overdose has been focused on investigating the mechanisms of hepatotoxicity, with limited success in advancing therapeutic strategies. Acute liver injury after any insult, including
APAP overdose, is followed by compensatory liver regeneration, which promotes recovery and is a crucial determinant of the final outcome. Liver regeneration after
APAP-induced liver injury is dose dependent and impaired after severe
APAP overdose. Although robust regenerative response is associated with spontaneous recovery and survival, impaired regeneration results in faster progression of injury and death after
APAP overdose.
APAP hepatotoxicity-induced liver regeneration involves a complex time- and dose-dependent interplay of several signaling mediators, including
growth factors,
cytokines, angiogenic factors, and other mitogenic pathways. Compared with the liver injury, which is established before most patients seek medical attention and has proved difficult to manipulate, liver regeneration can be potentially modulated even in late-stage
APAP-induced
acute liver failure. Despite recent efforts to study the mechanisms of liver regeneration after
APAP-induced liver injury, more comprehensive research in this area is required, especially regarding factors that contribute to impaired regenerative response, to develop novel regenerative
therapies for
APAP-induced
acute liver failure.